Newmont (NYSE: NEM) MD, Americas sells 8,060 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NEWMONT Corp executive David John Thornton, MD, Americas, reported an open-market sale of common stock. On March 3, 2026, he sold 8,060 shares of Newmont common stock at an average price of $120.78 per share, and now holds 27,264 shares directly.
The transaction was carried out under a pre-established Rule 10b5-1 trading plan dated December 1, 2025, indicating it was scheduled in advance rather than decided at the time of sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 8,060 shares ($973,487)
Net Sell
1 txn
Insider
Thornton David John
Role
MD, Americas
Sold
8,060 shs ($973K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $1.60 par value | 8,060 | $120.78 | $973K |
Holdings After Transaction:
Common Stock, $1.60 par value — 27,264 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did NEWMONT (NEM) report for David John Thornton?
NEWMONT reported that executive David John Thornton sold 8,060 shares of common stock in an open-market transaction at an average price of $120.78 per share. After this sale, he directly holds 27,264 Newmont shares, according to the Form 4 disclosure.
Was the NEWMONT (NEM) insider sale by David John Thornton under a 10b5-1 plan?
Yes. The Form 4 footnote states the sale was effected pursuant to a Rule 10b5-1 trading plan dated December 1, 2025. Such plans allow insiders to pre-schedule trades, helping separate routine portfolio management from trading based on nonpublic information.
What role does David John Thornton hold at NEWMONT (NEM)?
David John Thornton is identified as an officer of Newmont with the title MD, Americas. This means he is a senior executive overseeing Newmont’s Americas region, making his share transactions subject to Form 4 insider reporting requirements under U.S. securities regulations.